Navigation Links
Bioprocessing Facilities 2011 Conference to be held Aug. 8-9 in San Diego
Date:3/8/2011

ORINDA, Calif., March 8, 2011 /PRNewswire/ -- Management teams specializing in facilities, systems, and equipment for R&D, scale-up and manufacturing of biologics (biopharmaceuticals, vaccines, biotherapeutics and biodiagnostics) will meet at the Bioprocessing Facilities 2011 Conference Aug. 8-9 at the Hilton San Diego Resort to examine best-in-class industry solutions.

The conference will detail management experience, lessons learned, findings, and insights on cGMP bioprocessing facilities including new plans for reduced capital and operating costs; successful models for people and materials flow; implementation strategies for modular and disposable technologies; capacity planning approaches for mixed-use, multiproduct facilities; plans that maximize flexibility and speed to market; advances in MEP and processing equipment and more.

Speakers will include representatives from Fraunhofer USA, on their first-of-its-kind cGMP facility for plant-based protein production that does not require large-scale culturing or fermentation processes; Statens Serum Institute of Copenhagen, Denmark, an international research, production and service enterprise involved in vaccine and biologics development and diagnostic services; and Texas A&M's 155,000-sf National Center for Therapeutics Manufacturing (NCTM), which has the capacity for developing and producing multiple biological products using multiple production technologies.

For more information about Bioprocessing Facilities 2011, visit http://www.TradelineInc.com/Bioprocessing2011.

About Tradeline, Inc.

Tradeline, Inc. produces an annual series of conferences on leading-edge planning, design, and construction of facilities as well as the management of facilities portfolios and workplace support services. Tradeline is also an Internet publisher of breaking news, special reports, webcasts, and other resources enabling facilities professionals to make better investment and operating decisions for the future of their respective institutions.

For more information about Tradeline, visit http://www.TradelineInc.com.

Media contact: Bill Nothofer, Tradeline, Inc., (925) 254-1744, ext. 19; bnothofer@tradelineinc.com.


'/>"/>
SOURCE Tradeline, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Reportlinker Adds Frontiers in Carbohydrates Developments: Report 4; Research, Technologies; Biotechnology, Bioprocessing & Bioplastics - Food & Industrial Raw Material, January 2011
2. BioNeutrals Ygiene(TM) New Hospital Grade Disinfectant Will Save Lives and Billions of Dollars Annually at Health Care Facilities Around the World
3. Covanta Announces Amended Terms for its Acquisition of Two Biomass Energy Facilities in Maine
4. AARC Presentation Cites Masimo Patient SafetyNet as Key Factor in Improving Patient Outcomes and Reducing Costs in Post-Acute Care Facilities
5. Angiotech Pharmaceuticals, Inc. announces new Senior Secured Term Loan and Credit Facilities
6. VeraSun Energy Selects Valero as Successful Bidder for Seven Facilities
7. NIH News Confirms Trend in Stem Cell Storage Facilities, says CEO of San Diego-based Bio-Matrix Scientific Group
8. Peptimmune to Collaborate on Dengue Virus Vaccine and Point-Of-Care Diagnostic With Two DOD Biomedical Research Facilities
9. All TT Electronics Integrated Manufacturing Services Facilities Accredited with Medical Manufacturing Standard
10. Epeius Biotechnologies Corporation Expands its Rexin-G Production Facilities in Southern California
11. MedShape Solutions, Inc. Announces Commercialization of SBIR Funded Technology: Receives Purchasing Preference in Federally Funded Hospitals and Health Care Facilities
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 23, 2016   EpiBiome , a precision microbiome ... in debt financing from Silicon Valley Bank (SVB). The ... to advance its drug development efforts, as well as ... "SVB has been an incredible strategic partner to ... traditional bank would provide," said Dr. Aeron Tynes ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... at the Pennsylvania Convention Center and will showcase its product’s latest features from ... also be presenting a scientific poster on Disrupting Clinical Trials in The Cloud ...
(Date:6/23/2016)... India , June 23, 2016 ... media market research report to its pharmaceuticals section ... profiles, product details and much more. ... spread across 151 pages, profiling 15 companies and ... available at http://www.reportsnreports.com/reports/601420-global-cell-culture-media-industry-2016-market-research-report.html . ...
Breaking Biology Technology:
(Date:6/27/2016)... June 27, 2016 Research and Markets has ... 2016-2020" report to their offering. ... America to grow at a CAGR of 12.28% during ... based on an in-depth market analysis with inputs from industry experts. ... the coming years. The report also includes a discussion of the ...
(Date:6/22/2016)... , June 22, 2016  The American College of Medical ... Show Executive Magazine as one of the fastest-growing trade ... 25-27 at the Bellagio in Las Vegas ... highest percentage of growth in each of the following categories: ... companies and number of attendees. The 2015 ACMG Annual Meeting ...
(Date:6/22/2016)... 22, 2016   Acuant , the ... solutions, has partnered with RightCrowd ® ... Visitor Management, Self-Service Kiosks and Continuous Workforce ... add functional enhancements to existing physical access ... venues with an automated ID verification and ...
Breaking Biology News(10 mins):